Jan 15, 2024  |  4:00pm - 5:00pm

Harnessing antiviral responses to counter zoonotic viruses

Type
Monday seminar series
Tag(s)
Disruptive Innovation, Impactful research

As part of our Monday seminar series, we are delighted to welcome our speaker:

Talk title: Harnessing antiviral responses in reservoir bat species to develop next generation countermeasures against high consequence zoonotic viruses

Dr. Arinjay Banerjee
Principle Scientist
Laboratory of Zoonotic Viruses and Comparative Immunology (LZCI)
Vaccine and Infectious Disease Organization (VIDO)
Adjunct Lecturer, Department of Laboratory Medicine & Pathobiology

Hosted By

Dr. Samira Mubareka

How to join

The event will be in person only, no need to register.

MSB 2170

Medical Sciences Building
University of Toronto
1 King’s College Circle
Toronto, ON  M5S 1A8 

Details are sent to the LMP community in the Friday events bulletin.

If you have any questions about this event, please contact Debb Yorke at lmp.chairadmin@utoronto.ca.

Speaker: Dr. Arinjay Banerjee

Dr. Arinjay Banerjee (PhD) is a virologist and the Principal Investigator of the Laboratory of Zoonotic Viruses and Comparative Immunology at the Vaccine and Infectious Disease Organization, University of Saskatchewan. Dr. Banerjee is the co-lead for One Health at the University of Saskatchewan. 

Research within Dr. Banerjee’s laboratory focuses on three main themes that are inspired by the One Health ideology:

  1. virus-host interactions in wildlife reservoir species, such as bats,
  2. virus-host interactions in spillover species, such as humans, and
  3. viral vaccine development. 

Dr. Banerjee’s laboratory is a member of Canada’s Coronavirus Variants Rapid Response Network (CoVaRR-Net), and as part of this network, his laboratory investigates emerging SARS-CoV-2 variants. Research within Dr. Banerjee’s laboratory is funded by NIAID/NIH, CIHR, NSERC, SHRF and CoVaRR-Net.

Dr. Banerjee completed his Master of Science degree in virology from the National Institute of Virology in India where his Master’s thesis was awarded the university gold medal. Next, Dr. Banerjee completed his PhD from the University of Saskatchewan where his doctoral thesis on coronavirus-host interactions was awarded Canada’s Governor General’s Gold medal. Dr. Banerjee’s postdoctoral research at McMaster University was awarded the Gerard Wright postdoctoral award in Infection Research and the postdoctoral fellow impact award. More recently, Dr. Banerjee was selected as CBC Saskatchewan’s Top 40 under 40.

Dr. Arinjay Banerjee